The ␣v␤3 integrins are linked to human bleeding disorders, and pathogenic hantaviruses regulate the function of ␣v␤3 integrins and cause acute vascular diseases. ␣v␤3 integrins are present in either extended (active) or dramatically bent (inactive) structures, and interconversion of ␣v␤3 conformers dynamically regulates integrin functions. Here, we show that hantaviruses bind human ␣v␤3 integrins and that binding maps to the plexin-semaphorinintegrin (PSI) domain present at the apex of inactive, bent, ␣v␤3-integrin structures. Pathogenic hantaviruses [New York-1 virus (NY-1V) and Hantaan virus (HTNV)] bind immobilized ␤3 polypeptides containing the PSI domain, and human (but not murine) ␤3 polypeptides inhibit hantavirus infectivity. Substitution of human ␤3 residues 1-39 for murine ␤3 residues directed pathogenic hantavirus infection of nonpermissive CHO cells expressing chimeric ␣v␤3 receptors. Mutation of murine ␤3 Asn-39 to Asp-39 present in human ␤3 homologues (N39D) permitted hantavirus infection of cells and specified PSI domain residue interactions with pathogenic hantaviruses. In addition, cell-surface expression of ␣v␤3 locked in an inactive bent conformation conferred hantavirus infectivity of CHO cells. Our findings indicate that hantaviruses bind to a unique domain exposed on inactive integrins and, together with prior findings, suggest that this interaction restricts ␣v␤3 functions that regulate vascular permeability. Our findings suggest mechanisms for viruses to direct hemorrhagic or vascular diseases and provide a distinct target for modulating ␣v␤3-integrin functions.
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pathogenesis ͉ receptor P athogenic hantaviruses cause two human diseases with striking changes in vascular permeability: hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome (1) (2) (3) . Hantaviruses infect endothelial cells throughout the body, and pulmonary or renal manifestations may accompany either disease (1) (2) (3) . Unlike some hemorrhagic viruses, hantaviruses do not lyse endothelial cells, and alternate processes are required to explain vascular changes that direct pathogenesis. There are no therapeutic approaches for hantavirus diseases, and the cause of acute thrombocytopenia, edema, or vascular hemorrhage after hantavirus infections have not been defined.
Hemorrhagic diseases are caused by permeability changes within the vascular endothelium. ␤3 integrins on platelets (␣ IIb ␤3) and endothelial cells (␣v␤3) regulate vascular permeability (4) (5) (6) (7) (8) , and several human hemorrhagic diseases result from dysregulating ␤3-integrin functions (9-14). Glanzmann's disease is a human genetic ␤3-integrin-specific bleeding disorder hallmarked by thrombocytopenia and microvascular hemorrhage (9) . At least three autoimmune hemorrhagic diseases are caused by Ab responses to N-terminal residues of ␤3-subunits or to an atypical ␤3-integrin ligand (10) (11) (12) (13) (14) . Among these diseases, Goodpasture's syndrome is hallmarked by lethal pulmonary edema, hemorrhage, and glomerulonephritis (11, 13, 14) . Pathogenic hantaviruses also dysregulate ␤3-integrin functions (15) by means of atypical interactions with ␤3 (16), and the similarity of ␤3-integrin disorders to hantavirus pathogenesis suggests a further role for ␤3 integrins in viral hemorrhagic diseases (9) .
We have reported that Abs to ␤3-integrin subunits, as well as the high-affinity ␣v␤3-integrin ligand vitronectin, selectively inhibit infection by diverse pathogenic hantaviruses [hantavirus pulmonary syndrome: Sin Nombre virus (SNV) and New York-1 virus (NY-1V); hemorrhagic fever with renal syndrome: Hantaan virus (HTNV), Seoul virus (SEOV), and Puumala virus (PUUV)] (17, 18) . In contrast, nonpathogenic hantaviruses [Prospect Hill virus (PHV) and Tula virus (TULV)] were not inhibited by ␤3-integrin reagents, and the cellular entry of these viruses is consistent with the use of ␣5␤1 integrins (16) (17) (18) . Recombinant ␣v␤3 integrins expressed in CHO cells were shown to confer infection by only pathogenic hantaviruses, and infectivity was selectively blocked by ␤3 Abs. Also, the ability of endothelial cells to migrate on vitronectin is also selectively inhibited by infection with pathogenic, but not nonpathogenic, hantaviruses and results indicate that the function of ␣v␤3, rather than ␣v␤3 receptor levels, were selectively blocked by pathogenic hantaviruses (15) .
Arginine-glycine-aspartic acid (RGD) motifs direct ligand binding to several integrins, and RGD-containing peptides competitively inhibit ligand binding. Interestingly, RGD peptides do not inhibit hantavirus infection, and ␤3-integrin mutants, which are incapable of binding RGD or vitronectin, still direct the infection of CHO cells by pathogenic hantaviruses (17, 18) . These findings are consistent with the lack of RGD sequences within hantavirus G 1 and G 2 surface glycoproteins and are similar to Goodpasture's antigen, which was recently shown to be an RGD-independent ␤3-integrin ligand (19, 20) . These findings suggest that pathogenic hantaviruses recognize unique RGD-independent ␣v␤3-integrin domains (17, 18) and provide a compelling rationale for vascular diseases to emanate from hantavirus interactions with ␤3 integrins.
There has been little rationale for how hantaviruses might interact with ␣v␤3 integrins to explain the RGD independence of the interaction and hantavirus dysregulation of ␣v␤3 functions (17, 18) . However, recent crystal and EM structures of ␣v␤3 integrins demonstrate the presence of two dramatically different active and inactive ␣v␤3-integrin conformations, which are dynamically regulated (21) (22) (23) ). An activated ␣v␤3 conformation, directed by manganese ions, binds ligands through adjacent globular heads present at the apex of extended ␣v␤3-integrin heterodimers (21) . In contrast, calcium ions direct the formation of an inactive, bent ␣v␤3-integrin structure with heterodimeric integrin subunits folded nearly in half and masking ligand-binding head domains, which face the cell surface (21) . Bent ␣v␤3-integrin functions have not been reported, although the inactive conformation may present a unique RGD-independent target that could mediate hantavirus binding and regulate ␣v␤3-integrin functions.
In this article, we demonstrate that hantaviruses bind to residues within the plexin-semaphorin-integrin (PSI) domain (residues 1-53) present at the apex of the bent, inactive ␣v␤3 integrin and that recombinant bent integrins direct hantavirus entry into cells. We define ␤3-integrin residues that direct binding to human ␣v␤3 integrins and demonstrate that expressed human ␤3 polypeptides block hantavirus infection. These findings demonstrate hantavirus binding to ␣v␤3, explain ␤3-integrin regulation by pathogenic hantaviruses, and they provide a mechanism for hantavirus-directed vascular diseases. Our results suggest the utility of PSI domains on bent ␤3 integrins as targets for inhibiting hantavirus infection.
Materials and Methods
Cells and Virus. VeroE6 and CHO cells were grown in DMEM͞10% FCS as described (17) . Sf-9 cells were maintained in Grace's medium with 10% FCS or SF-900 (GIBCO). NY-1V, HTNV strain 76-118 (18) , and PHV were propagated on VeroE6 cells as described (0.5-1 ϫ 10 6 cells per ml) in a BSL-3 facility (17, 18) , and they were determined by PCR (Roche) to be mycoplasma-free.
Ligands, Peptides, and Abs. Vitronectin, fibronectin, and BSA were obtained from Sigma, and GRGDSP peptide was obtained from GIBCO. Rabbit sera to ␣v␤3 was kindly provided M. Roivainen (National Public Health Institute, Helsinki). Anti-human ␤3 (Ab 1932 and mAb1976) and ␣v mAb 1978 (clone LM-142) were obtained from Chemicon, and anti-murine ␤3 (CD61) was obtained from BD Biosciences. Rabbit anti-nucleocapsid polyclonal Abs, described in ref. 17 , were used to detect hantavirus-infected cells by immunoperoxidase staining. Horseradish peroxidase and FITC conjugates were obtained from The Jackson Laboratory.
Plasmids. Human ␤3 and human ␣v in pcDNA3.1-͞ZEO were provided by Barry Baxt (U.S. Department of Agriculture, Plum Island, NY), and murine ␤3 in pREP9 was provided by Eric Brown (University of California, San Francisco). ␣v and ␤3 pCDM8 clones (A) ␣v␤3 heterodimers were secreted from baculovirus infected Sf-9 cells as described (25) . Secreted ␣v␤3 was purified by using ConA, followed by RGD-affinity chromatography (25) , and detected by silver stain or Western blot analysis with rabbit anti-␣v␤3. (B) Purified ␣v␤3 was incubated with NY-1V, HTNV, and PHV (DMEM͞2% FCS) before adsorption to VeroE6 cells. Infected cells were methanol-fixed at 24 h after infection, immunoperoxidase-stained for hantavirus N-protein, and quantitated (17) . ConA-and RGD-purified material from Bac-Rec-VP5-infected (26) Sf-9 cell supernatants was used as a control. Rabbit anti-␣v␤3 (10 g) binding to ␣v␤3 prevented ␣v␤3 from inhibiting infection. Results are presented as a percentage of infected cells (n Ϸ 100) in the absence of ␣v␤3 and represent three independent experiments. (C) mAb LM-142 was bound to protein A͞G resin and coated with secreted purified ␣v␤3 (500 ng). Vitronectin, fibronectin, RGD peptides (20 g͞l), or BSA were adsorbed to ␣v␤3 resin in DMEM͞2% FCS. NY-1V (5000 FFU) was adsorbed to untreated or protein-treated resin (2 h at 25°C). After washing (five times with DMEM͞2% FCS), resin and bound virus were applied to VeroE6 cells, monolayers were washed, and at 48 h after infection, hantavirus-infected cells were quantitated, as shown in B. In two samples, NY-1V was pretreated with either secreted ␣v␤3 (200 ng) or control Sf-9 supernatent (Fig. 1B ) before adsorption to resin containing ␣v␤3. Data are expressed as the percentage of control (resin without ␣v␤3). At least three independent experiments were performed with similar results. (D) ␤3-Integrin homologue swaps CHO cells expressing full-length Hu␣v. Indicated human or murine ␤3 integrins or ␤3-integrin chimeras were analyzed by FACS for ␣v␤3 and infected with pathogenic NY-1V, HTNV, or PHV (Ϸ1,000 FFU) as described above, and cells were quantitated as in B at 24 h after infection. Chimeric ␤3 integrins (1-762) contain indicated human ␤3 residues inserted into a murine ␤3-integrin background. Data are expressed as percentage of mock-transfected CHO cells, and experiments were performed at least three times with similar results.
were provided by Mark Ginsberg (The Scripps Research Institute, La Jolla, CA). Murine ␤3 was subcloned into pcDNA3.1-͞ZEO and chimeric ␤3-integrin constructs were generated as described in Table 1 , which is published as supporting information on the PNAS web site. Recombinant ␣v and ␤3 expression plasmids (H␣v-G307C and H␤3-R563C) were provided by Tim Springer (Harvard University, Boston) (21 , and M␤3-N39D were generated by oligonucleotide-directed mutagenesis (Stratagene), sequenced, and evaluated for surface expression of ␣v␤3 by FACS analysis (15) . N-terminal fragments containing residues 1-136 and 1-53 of H␤3 and M␤3 were subcloned from human or murine ␤3 plasmids into pET6His (24) at the BamHI site. The ectodomains of human ␣v (amino acids 1-969) and ␤3 (amino acids 1-692) (25) were PCRamplified from pCDM8 plasmids (17) and cloned into pAcUW51 (Pharmingen) at the EcoRI (␣v; p10 promoter) and BamHI (␤3; polyhedron promoter) sites.
Protein Expression and Purification. Recombinant baculoviruses were generated by using pAcUW51 constructs and BaculoGold DNA (BD Biosciences), and expressed ␣v␤3 was secreted from Sf-9 cell supernatants as described (25) . Secreted ␣v␤3 was purified by Con A-Sepharose 4B chromatography, elution with 30 mM ␣-methyl-D-mannoside and binding to RGD-Sepharose (0.5 mg of GRGDSPK coupled to cyanogen-bromide-activated Sepharose 4B). ␣v␤3 was eluted with 0.2 M EDTA, dialyzed against PBS, and analyzed by SDS͞PAGE and silver staining (Bio-Rad) or Western blotting with a rabbit anti-␣v␤3. Control preparations were ConA-and RGD-purified from supernatants of Sf-9 cells expressing a nonsecreted rotavirus protein VP5 (BacRec-VP5) (26) .
Proteins were expressed from pET6His plasmids (24) . Isopropyl ␤-D-thiogalactoside (IPTG) induction (1 mM for 3 h) was performed at 37°C for ␤3 1-136 and at 30°C for ␤3 1-53 polypeptides. Bacteria were resuspended in 0.1 M NaH 2 PO 4 ͞10 mM Tris⅐HCl͞1 M urea, sonicated, and purified by using Ni 2ϩ -nitrilotriacetic acid resin (Qiagen, Valencia, CA) (24) . Proteins were eluted with 0.5 M EDTA, dialyzed overnight in PBS (3.5-kDa cutoff), and quantitated by bicinchoninic acid (BCA) assay (Pierce).
Inhibiting Infectivity. NY-1V, HTNV, or PHV [Ϸ1,000 focusforming units (FFU)] were incubated with polypeptides (2 h on ice), and then adsorbed to duplicate wells (100 l per well) of VeroE6 cells in 96-well plates (1 h at 37°C). Monolayers were washed with DMEM͞2% FCS, and cells were incubated for 24 h, methanol-fixed, immunoperoxidase-stained for nucleocapsid protein, and quantitated (17) .
Transfection and Infection. CHO cells were transfected (FuGene 6, Roche) with equal amounts of human ␣v and ␤3 plasmids (pcDNA3.1, 1.5 g) and selected with G418 and Zeocin (500 g͞ml). Cells expressing ␣v␤3 integrins were incubated with mAb 1976 or anti-CD61 (murine ␤3) anti-mouse FITC, and they were sorted by using a FACSCalibur cell sorter (BD Biosciences) as described (15) . Cells expressing similar levels of ␣v␤3 on their surface were collected (GeoMean 12-16) and used for infectivity experiments ( Table 2 , which is published as supporting information on the PNAS web site). Transfected and mocktransfected cells were infected with hantaviruses as described above, fixed at 24 h after infection, immunoperoxidase-stained for hantavirus nucleocapsid protein. Experiments using H␣v-G307C͞H␤3-R563C (locked bent) and H␤3-C5A (locked extended) were performed doubly blinded, with coded samples transfected and quantitated independently. Viral Binding. Protein A͞G beads (Santa Cruz Biotechnology) were preincubated with mAb 1978 (anti-␣v, LM-142, nonblocking) and adsorbed to 1 mg of purified secreted human ␣v␤3 in DMEM͞2% FCS or with BSA (1 mg) in control purified Sf-9 supernatants (SF-900). NY-1V (Ϸ5,000 FFU) was adsorbed to ␣v␤3 or control resin (2 h at 25°C) and washed with DMEM͞2% FCS, and resin containing bound virus was adsorbed to duplicate wells of VeroE6 cells and virus-infected cells were quantitated 48 h after infection. Purified ␤3 polypeptides containing residues 1-136 (4 g per 15 l of resin) were bound to Ni 2ϩ -nitrilotriacetic acid beads for 30 min at 25°C. NY-1V or HTNV (Ϸ5,000 FFU) were bound to resin and washed, and the amount of infectious virus bound to resin was quantitated as described above.
Results
Commercial preparations of ␣v␤3 integrins are extracted from membranes, contain hydrophobic anchor sequences, and are present in detergent that is deleterious to enveloped viruses. To define hantavirus interactions with ␣v␤3 integrins, we expressed and RGD-purified the ectodomains of the human ␣v␤3 as secreted heterodimers (Fig. 1A) (25) . As reported (25) , secreted ␣v␤3 contained two ␣v bands that are consistent with the presence of partially cleaved posttranslational ␣v products. Incubating increasing amounts of purified ␣v␤3 with virus before Fig. 2 . Binding to residues 1-136. Ni 2ϩ -NTA resin was incubated with 4 g of a human or murine ␤3 polypeptides (residues 1-136; Fig. 7) . NY-1V, HTNV, or PHV (Ϸ5,000 FFU) were incubated with resin in DMEM͞2% FCS (2 h, 25C). Resin was washed (five times, DMEM͞2% FCS), and resin and bound virus were applied to VeroE6 cells and analyzed as described for Fig. 1C . The mean number of infected cells in the control (resin alone) was Ϸ100, and experiments were performed at least three times with similar results. Fig. 7 ) were incubated (2 h at 4°C in DMEM͞2% FCS) with NY-1V, HTNV, and PHV, and they were subsequently adsorbed to VeroE6 cells. Polypeptide quantities are indicated as follows: none, black; 0.75 M, white; 1.5 M, dark gray; 3.0 M, hatched; and 6 M, light gray). Cells were washed, and infected cells at 24 h after infection were quantitated as described for Fig. 1B . The mean number of infected cells in controls (no added polypeptides) was Ϸ60, and experiments were performed at least three times with similar results. adsorption inhibited infection by pathogenic NY-1V and HTNV but had no effect on PHV (Fig. 1B) . These data support our previous findings that only pathogenic hantaviruses use ␣v␤3 integrins (17, 18) , and they suggest that purified ␣v␤3 might serve as a platform for viral-binding experiments.
Low-hantavirus titers have made binding assays using conventional viral-labeling approaches difficult. To bypass this limitation, viral binding was assayed by monitoring binding of infectious virus to ␣v␤3 immobilized on protein A͞G resin. Resin was incubated with NY-1V in the presence of indicated proteins in DMEM͞2% FCS, washed, and bound infectious virus was quantitated. Immobilized ␣v␤3 bound NY-1V, and similar to infection studies, neither RGD peptides nor fibronectin inhibited NY-1V binding to purified ␣v␤3. However, NY-1V binding was inhibited specifically by the high-affinity ␣v␤3 ligand vitronectin (17, 18) , as well as by soluble ␣v␤3. These results support our previous studies (17, 18) , indicating that NY-1V, HTNV, Seoul virus (SEOV), and Puumala virus (PUUV) infections were blocked by vitronectin but not by RGD or fibronectin ligands. These findings demonstrate that NY-1V binds directly to ␣v␤3, and as a result, ␣v␤3 is a cellular receptor for pathogenic hantaviruses.
Human, but not murine, ␤3-integrin subunits permit hantavirus infection of CHO cells, and infection does not depend on the source of ␣v (16) . These findings and the conservation of ␤3-subunits permitted us to map domains of human ␤3 that permit hantavirus infection when substituted for murine ␤3 residues (Fig. 1D) . Plasmids expressing chimeric human͞murine ␤3-subunits (Fig. 6 , which is published as supporting information on the PNAS web site) were cotransfected into cells along with human ␣v expression plasmids. Cells were sorted for similar levels of ␣v␤3-integrin expression (Table 2) as described (15) , and hantavirus infection was evaluated. Fig. 1D indicates that all chimeras containing residues 1-43 of the human ␤3 integrin direct the cellular entry of NY-1V and HTNV, but not PHV (Fig.  6 ). These findings map integrin requirements for hantavirus infection to residues outside the RGD-binding site and within the PSI homology domain at the N terminus of ␤3 (27) .
We bacterially expressed and purified N-terminal ␤3-integrin polypeptides (1-136 and 1-53) (Fig. 7 , which is published as supporting information on the PNAS web site) to determine whether they were capable of binding hantaviruses (Fig. 2) or inhibiting hantavirus infectivity (Fig. 3) . Similar to ␣v␤3-binding experiments, residues 1-136 of human, but not murine, ␤3-subunits were capable of binding pathogenic NY-1V and HTNV (Fig. 2) . In addition, when used as a potential competitor of hantavirus infectivity, pretreatment of NY-1V or HTNV with increasing amounts of human, but not murine, ␤3 polypeptides (1-53 shown) blocked viral infection of VeroE6 cells (Fig. 3) . These findings indicate that human polypeptides of N-terminal ␤3-integrin domains bind hantaviruses and are capable of competitively inhibiting NY-1V and HTNV infection.
There are only eight amino acid differences between residues 1-53 of human and murine ␤3 integrins and all changes reside within residues 1-39 (Fig. 4A) . Bovine ␤3-subunits also fail to permit hantavirus infection (Fig. 8 , which is published as supporting information on the PNAS web site), and there are only three residue differences between human and bovine ␤3-subunits in this region. Murine and bovine residue differences coincide, and as a result, we mutagenized coincident and adjacent murine ␤3 residues to homologous human residues (V22M, SQ32͞33PL, and N39D). Mutant polypeptides (residues 1-53) were evaluated as inhibitors of hantavirus infection and compared with WT human or murine polypeptides (Figs. 4B and 9 , which is published as supporting information on the PNAS web site). Changing murine residues 32͞33 resulted in a polypeptide that reduced NY-1V infection by 25%, with little if any effect on HTNV. Altering residue 22 did not affect infection by any hantavirus, and the infectivity of PHV was unaffected by any of the tested polypeptides. In contrast, the N39D change within the murine ␤3 1-53 polypeptide inhibited NY-1V (75%), identically to the human ␤3 polypeptide, although they inhibit infection of Only three residues differ between human and bovine ␤3 (underlined). (B) Indicated murine ␤3-subunit residues were mutated to homologous human residues and expressed in 6-His-tagged 1-53 polypeptides. Mutant polypeptides (6 M) were added during adsorption and assayed for their ability to inhibit infection as in Fig. 3 . The mean number of infected cells in the controls (media alone) was Ϸ60, and experiments were repeated at least three times with similar results. (C) CHO cells (expressing Hu␣v and WT or mutated murine ␤3 integrins substituted with homologous human ␤3 residues at indicated positions) were analyzed by FACS for ␣v␤3 and assayed for their ability to confer hantavirus infection as in Fig. 1D . The mean number of infected cells in control CHO cells was Ϸ15, and results are representative of three independent experiments.
HTNV by Ϸ56% (Fig. 4B) . This result identified a single residue difference between human and murine ␤3 that is required for inhibiting infection by NY-1V and HTNV.
Identical changes were made in full-length murine ␤3-integrin subunits, which were expressed on CHO cells and analyzed by FACS, as described above, for similar expression levels of ␣v␤3 (Fig. 4C) . Only murine ␤3 recombinants with the N39D residue change permitted pathogenic NY-1V or HTNV hantavirus infection when expressed on CHO cells (Figs. 4C and 9 ). There was no apparent affect of other mutations on hantavirus infection, and PHV infectivity was unaffected by expression of any ␣v␤3 integrins. These findings indicate that aspartic acid 39 within human ␤3 PSI domains is required for infection by pathogenic NY-1V and HTNV.
The conformation of ␣v␤3-integrin heterodimers are dynamically regulated by divalent cations, with calcium favoring bent integrin conformers and manganese directing extended ␣v␤3-integrin conformations (21) (22) (23) . Structural analysis indicates that ␤3 PSI domains are present at or near the apex of bent ␣v␤3 conformers and likely in an inaccessible position half-way down the heterodimeric stalk of the extended integrin (22, 23) . Hantavirus interactions with PSI domains suggest that hantavirus infection may similarly be determined by divalent cations and ␣v␤3-integrin conformations. To address this possibility, we pretreated VeroE6 cells with manganese or calcium ions and evaluated hantavirus infection. Fig. 5A indicates that infection by NY-1V and HTNV were enhanced by calcium and inhibited by manganese ions. These results are consistent with NY-1V and HTNV interactions with apical PSI domains exposed on the surface of bent ␣v␤3-integrin conformers.
To determine whether hantaviruses selectively interact with bent integrin conformers, we expressed recombinant ␣v␤3 integrins that are locked into bent (21) or extended (28) forms on the surface of nonpermissive CHO cells. Cells were sorted for similar levels of expressed ␣v␤3 integrins on their surface as described above and hantavirus infected. Expression of locked extended ␣v␤3-integrin conformers failed to confer hantavirus infection (Fig. 5B) . In contrast, locked bent ␣v␤3-integrin conformers enhanced NY-1V and HTNV infection of cells, similar to cells expressing unmodified human ␣v␤3 integrins (Fig. 5B) .
Collectively, our findings demonstrate that hantaviruses bind to residues within the ␤3-integrin PSI domain that is exposed on the surface of bent ␣v␤3-integrin structures (Fig. 5C ).
Discussion
We have demonstrated that ␤3 integrins direct the infection of cells by several divergent pathogenic, but not nonpathogenic, hantaviruses (16) (17) (18) . We further determined that infection by pathogenic hantaviruses selectively inhibited the migration of endothelial cells on the high-affinity ␣v␤3-integrin ligand vitronectin, demonstrating that pathogenic hantaviruses dysregulated ␣v␤3-integrins functions after infection (15) . ␤3-integrin interactions were RGDindependent, and collectively, these studies tied hantavirus pathogenesis to the use and regulation of ␤3 integrins (15) (16) (17) (18) . However, there was no understanding of RGD-independent ligand interactions with ␣v␤3 or rationales for ␣v␤3-integrin functions to be inhibited by non-RGD-directed ligands. Recent structural studies of ␣v␤3 (21-23, 27, 29, 30) have provided a compelling rationale for hantavirus interactions that explain these findings. Dramatic conformational changes of ␣v␤3 switch the integrin from active (ex- tended) to inactive (bent) ligand-binding states (27) , dynamically regulating RGD ligand-binding functions of ␣v␤3, and exposing new domains on bent integrins that may facilitate integrin regulation. Bent ␣v␤3-integrin conformations provide a mechanism by which RGD-independent interactions of hantaviruses dysregulate normal ligand-binding functions of ␣v␤3.
Our findings demonstrate that pathogenic NY-1V and HTNV bind PSI domains within ␤3-integrin subunits that are present at the apex of bent ␣v␤3-integrin conformations. Residues within the PSI domain determine hantavirus-binding interactions and expression of locked bent ␣v␤3 integrins confer cell susceptibility to NY-1V and HTNV. These findings indicate that pathogenic hantaviruses use domains exposed on bent ␣v␤3-integrin conformers, and they suggest a mechanism for the regulation of ␣v␤3-integrin functions by pathogenic hantaviruses. RGD-independent interactions of hantaviruses with ␤3 PSI domains are likely to lock ␣v␤3 integrins into a bent conformation and are consistent with hantavirus dysregulation of ␣v␤3 functions after infection (15) .
Hantavirus binding and infectivity are centered on RGDindependent interactions with ␤3-integrin PSI domains. PSI domains are present at the apex of bent ␣v␤3 integrins (22, 23, 29) and may play important roles in regulating integrins, although there is little understanding of PSI domain functions or binding interactions (31) . PSI-domain homologies are defined by the position of a tryptophan relative to five to eight cysteine residues with highly divergent intervening sequences (8, 27, 31) . A greater understanding of PSI domains is complicated by the recent assignment of PSI-domain disulfide bonds from structural data that are entirely different from mutagenic and biochemical assignments (8, 32) . Residue 39 is partially exposed on PSI domains (27) and appears to be critical for polypeptides to inhibit hantavirus infectivity and required for hantavirus infection of cells (Fig. 4 B and C) . This residue is also adjacent to cysteine 38 and, as a result, changes at this position could cause large changes in exposed surfaces of PSI domains (32) . However, the ability of bacterially expressed polypeptides to inhibit hantavirus infection suggests that primary rather than secondary PSI domain structures determine hantavirus ␤3-binding specificity (8) .
␤3 integrins are directly linked to acute hemorrhagic diseases, which include Glanzmann's disease, fetomaternal alloimmune thrombocytopenia (FMAIT), posttransfusion purpuria (PTP), and Goodpasture's syndrome (9, 20, 33) . Similar to these diseases, hantaviruses block ␤3-integrin functions (15) and have prominent thrombocytopenia and vascular permeability defects, which include edema and hemorrhage. Genetic mutations in ␤3 integrins cause hemorrhagic disease (9) . Immune recognition of ␤3-integrin isoforms, differing in a single PSI-domain residue (L33P), appears to be responsible for FMAIT and PTP (10, 33) , whereas immune recognition of Goodpasture's antigen, an RGD-independent ligand of ␣v␤3 (13, 14, 19, 20) , similarly directs vascular disease. In autoimmune bleeding disorders, acute disease is followed by long recovery times and coincides with waning Ab responses of patients (10) (11) (12) (13) (14) 33) . Interestingly, Goodpasture's syndrome and hantavirus diseases have common pulmonary and renal disease tropisms as well as edematous and hemorrhagic effects (1-3, 11, 13, 14) . Immune complexes have been suggested to play a role in hantavirus disease and may contribute to long disease onset, increased severity of hantavirus disease in healthy young adults, and long recovery periods that may depend on waning Ab responses (1-3). It is currently unknown whether hantaviruses direct similar autoimmune responses; however, the similarity of hantavirus diseases to other ␤3-integrin-directed vascular diseases provides a rationale for evaluating hantavirus-directed autoimmune responses, which may contribute to hantavirus pathogenesis.
Pathogenic hantaviruses cause diseases with striking similarity to ␤3-directed hemorrhagic diseases with pulmonary and renal effects. We have defined ␣v␤3-specific peptide inhibitors that block hantavirus infection and have therapeutic implications for hantavirus diseases. Our findings further indicate that pathogenic hantaviruses bind to PSI domains present at the apex of bent inactive ␤3 integrins and these data define an explicit ␤3 target for the development of highly selective hantavirus therapeutics. Because ␤3 integrins also play prominent roles in vascular disease, tumor invasion and angiogenesis, PSI domains may also serve as therapeutic targets for a wide variety of ␣v␤3-directed anomalies.
